🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-04-13
Trial ID
NCT05799079
Treatments Being Tested
A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Status
Completed
Location
Hospital Universitario Príncipe de Asturias
Start Date
2020-11-04
Trial ID
NCT04687761
Treatments Being Tested
This phase I/II trial investigates the side effects and best dose of veneto...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-09-04
Trial ID
NCT04550442
Treatments Being Tested
This investigator-initiated, single-arm, phase II trial is aimed to evaluat...
Status
Recruiting
Location
Ethical Committee of the First Affiliated Hospital of Soochow University
Start Date
2024-01-01
Trial ID
NCT06429098
Treatments Being Tested
This phase II trial tests how well venetoclax with cladribine and cytarabin...
Status
Recruiting
Location
University of Miami Miller School of Medicine-Sylvester Cancer Center
Start Date
2025-01-03
Trial ID
NCT06504459
This is a Phase I/II clinical study to determine the maximum tolerated dose...
Status
Terminated
Location
Research Site
Start Date
2017-07-31
Trial ID
NCT03217838
Treatments Being Tested
Open-label phase II, single arm, multicenter study with safety run-in to ev...
Status
Active Not Recruiting
Location
CHU d'Amiens
Start Date
2023-10-04
Trial ID
NCT05768711
Treatments Being Tested
This research is being done to assess the therapeutic efficacy and safety o...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Start Date
2022-03-01
Trial ID
NCT05177731
Treatments Being Tested
This is a Phase 1 dose-escalation study of PRT1419, a myeloid cell leukemia...
Status
Terminated
Location
Mid Florida Hematology and Oncology Center
Start Date
2022-03-22
Trial ID
NCT05107856
Treatments Being Tested